Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study.

MLA

Ceynowa-Sielawko, Beata, et al. “Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study.” International Journal of Environmental Research and Public Health, vol. 19, no. 8, Apr. 2022. EBSCOhost, https://doi.org/10.3390/ijerph19084880.

APA

Ceynowa-Sielawko, B., Wybraniec, M. T., Topp-Zielińska, A., Maciąg, A., Miśkowiec, D., Balsam, P., Wójcik, M., Wróbel, W., Farkowski, M. M., Ćwiek-Rębowska, E., Ozierański, K., Błaszczyk, R., Bula, K., Dembowski, T., Peller, M., Krzowski, B., Wańha, W., Koziński, M., Kasprzak, J. D., … Szołkiewicz, M. (2022). Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study. International Journal of Environmental Research and Public Health, 19(8). https://doi.org/10.3390/ijerph19084880

Chicago

Ceynowa-Sielawko, Beata, Maciej T Wybraniec, Aleksandra Topp-Zielińska, Aleksander Maciąg, Dawid Miśkowiec, Paweł Balsam, Maciej Wójcik, et al. 2022. “Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study.” International Journal of Environmental Research and Public Health 19 (8). doi:10.3390/ijerph19084880.